← FDA DRUG APPROVALS

FDA NDA · NDA012594

METAHYDRIN

Sponsor: SANOFI AVENTIS US

APPLICATION
NDA012594
TYPE
NDA
LATEST ACTION
1994-01-28
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

METAHYDRINDiscontinued
TRICHLORMETHIAZIDE 2MG · TABLET · ORAL
METAHYDRINDiscontinued
TRICHLORMETHIAZIDE 4MG · TABLET · ORAL

Approval history

1994-01-28Labeling · Supplement 18 · standardAP
1989-06-23Labeling · Supplement 17 · standardAP
1988-06-16Labeling · Supplement 13 · standardAP
1988-06-16Manufacturing (CMC) · Supplement 8 · standardAP
1988-06-16Manufacturing (CMC) · Supplement 16 · standardAP
1988-06-16Manufacturing (CMC) · Supplement 15 · standardAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →